+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Immunohistochemical detection of K-sam protein in stomach cancer



Immunohistochemical detection of K-sam protein in stomach cancer



Clinical Cancer Research 2(8): 1373-1381



The K-sam gene, originally isolated as an amplified gene from the stomach cancer cell line KATO-III, is characterized by its preferential amplification in the undifferentiated type (diffuse type) of stomach cancer and encodes one of the receptors for heparin-binding growth factors or fibroblast growth factors. The K-sam gene has been isolated by different methods and has been designated BEK, TK14, and Cek2. The receptor for keratinocyte growth factor was also found to be encoded by the same gene. To examine the expression of the K-sam protein in stomach cancer, polyclonal antibody pK1-2 was raised against the extracellular domain of the gene product. This antibody detected K-sam proteins by Western blot and flow cytometry analyses in stomach cancer cell lines KATO-III and HSC39, in which the K-sam gene is amplified and overexpressed. By immunohistochemical analysis, 20 of 38 cases of the undifferentiated type of advanced stomach cancer were K-sam positive, whereas none of 11 cases of the differentiated or intestinal type revealed K-sam staining. The K-sam product was observed predominantly in diffusely infiltrative lesions. In one autopsy case, the K-sam protein was detected only focally in the primary tumor, whereas markedly increased staining for the K-sam product was detected diffusely in the metastasized tumor in the lymph node and liver. These results suggest that K-sam overexpression is associated with the malignant phenotype of the undifferentiated type of stomach cancer, such as infiltrative growth and metastasis.

(PDF emailed within 1 workday: $29.90)

Accession: 046333970

Download citation: RISBibTeXText

PMID: 9816310


Related references

Detection of tenascin in stomach cancer. An immunohistochemical study. Zentralblatt für Pathologie 140(2): 123-128, 1994

Immunohistochemical detection of WT1 protein in endometrial cancer. Anticancer Research 29(5): 1691-1695, 2009

Immunohistochemical detection of p53 protein in human prostatic cancer. Journal of Urology 152(4): 1297-1301, 1994

Immunohistochemical Detection of p53 Protein as a Prognostic Indicator in Prostate Cancer. Human Pathology. 26(1): 106-109, 1995

Serological and immunohistochemical detection of a 65-kDa oncofetal protein in breast cancer. European Journal of Cancer 30a(8): 1108-1113, 1994

Immunohistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer. BJU International 90(4): 462-466, September, 2002

Presentation of a case of stomach cancer at the onset detected by "systematic mass gastric examination for early detection of cancer of the stomach". Annales de Gastroenterologie et D'hepatologie 6(4): 319-324, 1970

Immunohistochemical assay for detection of K-ras protein expression in metastatic colorectal cancer. Journal of the Egyptian National Cancer Institute 25(1): 51-56, 2013

Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non-small-cell lung cancer. Journal Of Thoracic & Cardiovascular Surgery. 109(6): 1205-1211, 1995

Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women. Anticancer Research 21(1b): 743-748, 2001

Immunohistochemical detection of p53 protein accumulation in head and neck cancer: Correlation with p53 gene alterations. Human Pathology 30(10): 1221-1225, 1999

Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer. Cancer Detection and Prevention 21(5): 418-425, 1997